Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

[A case of myocardiac metastasis of clear cell renal carcinoma successfully treated with sunitinib].

Tatenuma T, Yao M, Sakata R, Sano F, Makiyama K, Nakaigawa N, Nakayama T, Inayama Y, Kubota Y.

Hinyokika Kiyo. 2013 Feb;59(2):97-101. Japanese.

2.

[Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma].

Morizawa Y, Momose H, Toyoshima Y, Takada S, Fujimoto K, Oyama N.

Hinyokika Kiyo. 2013 Dec;59(12):791-3. Japanese.

3.

[PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].

Namura K, Otake S, Sawada T, Fujikawa A, Ota J, Moriyama M.

Nihon Hinyokika Gakkai Zasshi. 2015 Jan;106(1):30-4. Japanese.

PMID:
26399128
4.

[Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case].

Tsuchiyama K, Ito H, Ishida H, Itoh H, Yokoyama O.

Hinyokika Kiyo. 2011 Nov;57(11):615-8. Japanese.

5.

[A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].

Komeya M, Matsumoto T, Fujinami K, Senga Y, Asakura T, Goto A.

Hinyokika Kiyo. 2010 Sep;56(9):499-503. Review. Japanese.

6.

Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.

Zeng H, Li X, Yao J, Zhu Y, Liu J, Yang Y, Qiang W.

Urol Int. 2009;83(4):482-5. doi: 10.1159/000251193. Epub 2009 Dec 8.

PMID:
19996660
7.

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma.

Elfiky AA, Cho DC, McDermott DF, Rosenberg JE, Fortner B, Antràs L, Chen K, Sheng Duh M, Jayawant SS, Oh WK, Atkins MB, Choueiri TK.

Urol Oncol. 2011 Nov-Dec;29(6):756-63. doi: 10.1016/j.urolonc.2010.01.008. Epub 2010 May 6.

PMID:
20451414
8.

Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.

Seidel C, Fenner M, Merseburger AS, Reuter C, Ivanyi P, Länger F, Ganser A, Grünwald V.

World J Urol. 2011 Jun;29(3):355-60. doi: 10.1007/s00345-010-0642-3. Epub 2011 Jan 22.

PMID:
21258806
9.

[A case of interstitial lung disease due to sunitinib].

Sekiguchi Z, Takizawa A, Takeshima T, Tsuchiya F, Iwasaki A, Matsuyama S, Hirooka N.

Hinyokika Kiyo. 2012 Sep;58(9):481-5. Japanese.

10.

An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib.

Pwint TP, Macaulay V, Roberts IS, Sullivan M, Protheroe A.

Urol Oncol. 2011 Nov-Dec;29(6):821-4. doi: 10.1016/j.urolonc.2009.10.007. Epub 2009 Dec 4.

PMID:
19962921
11.

[Cardiac tamponade due to pericardial metastasis from renal cell carcinoma : a case report].

Ueda N, Arai Y, Matsuzaki K, Yamamoto Y, Takeda K, Nakata W, Nakayama M, Kakimoto K, Nishimura K.

Hinyokika Kiyo. 2012 Sep;58(9):491-4. Japanese.

12.

Long-term stable disease in metastatic renal cell carcinoma: sorafenib sequenced to sunitinib and everolimus: a case study.

Beck J, Bellmunt J, Escudier B.

Med Oncol. 2011 Dec;28(4):1379-83. doi: 10.1007/s12032-010-9589-x. Epub 2010 Jul 1.

PMID:
20593250
13.

Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy.

Lim ZD, Mahajan A, Weinberg J, Tannir NM.

Am J Clin Oncol. 2013 Jun;36(3):258-60. doi: 10.1097/COC.0b013e3182467b9a.

PMID:
22441343
14.

Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience.

Ansari J, Fatima A, Fernando K, Collins S, James ND, Porfiri E.

Oncol Rep. 2010 Aug;24(2):507-10.

PMID:
20596640
15.

Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.

Zimmermann K, Schmittel A, Steiner U, Asemissen AM, Knoedler M, Thiel E, Miller K, Keilholz U.

Oncology. 2009;76(5):350-4. doi: 10.1159/000209961. Epub 2009 Mar 24.

PMID:
19321976
16.

Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma.

Heng DY, Rini BI, Garcia J, Wood L, Bukowski RM.

Clin Genitourin Cancer. 2007 Dec;5(7):446-51. doi: 10.3816/CGC.2007.n.033.

PMID:
18272027
17.

Prostatic metastasis of renal cell carcinoma successfully treated with sunitinib.

Fokt RM, Templeton A, Gillessen S, Ohlschlegel C, Schmid HP.

Urol Int. 2009;83(1):122-4. doi: 10.1159/000224882. Epub 2009 Jul 27. Review.

PMID:
19641373
18.

[A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].

Ohtake S, Namura K, Fujikawa A, Sawada T, Ohta J, Moriyama M, Hayashi H.

Hinyokika Kiyo. 2014 Feb;60(2):75-8. Japanese.

19.

[Myocardial metastasis from renal cell carcinoma treated with sorafenib].

Tokuyama Y, Iwamura M, Fujita T, Sugita A, Maeyama R, Bessho H, Ishikawa W, Tabata K, Yoshida K, Baba S.

Hinyokika Kiyo. 2011 Oct;57(10):555-8. Review. Japanese.

20.

Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.

Kayani I, Avril N, Bomanji J, Chowdhury S, Rockall A, Sahdev A, Nathan P, Wilson P, Shamash J, Sharpe K, Lim L, Dickson J, Ell P, Reynolds A, Powles T.

Clin Cancer Res. 2011 Sep 15;17(18):6021-8. doi: 10.1158/1078-0432.CCR-10-3309. Epub 2011 Jul 8.

Items per page

Supplemental Content

Write to the Help Desk